ES475905A1 - Test method for detection of malignant tumours - Google Patents

Test method for detection of malignant tumours

Info

Publication number
ES475905A1
ES475905A1 ES475905A ES475905A ES475905A1 ES 475905 A1 ES475905 A1 ES 475905A1 ES 475905 A ES475905 A ES 475905A ES 475905 A ES475905 A ES 475905A ES 475905 A1 ES475905 A1 ES 475905A1
Authority
ES
Spain
Prior art keywords
mif
lymphocytes
contacted
intermediate layer
migration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES475905A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
R and Z Vermogensverwaltungsgesellschaft MbH
Original Assignee
R and Z Vermogensverwaltungsgesellschaft MbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R and Z Vermogensverwaltungsgesellschaft MbH filed Critical R and Z Vermogensverwaltungsgesellschaft MbH
Publication of ES475905A1 publication Critical patent/ES475905A1/en
Expired legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Physiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)

Abstract

An in vitro testing method for the diagnosis of malignant tumours preferably human tumours, by determining the mobility variation of cellular blood components contacted with a migration inhibition factor (MIF), the MIF being secreted from lymphocytes being sensitized against tumour tissue, comprises subjecting, as said cellular blood components, the lymphocytes contained in a leucocyte suspension to be examined to a migration inhibition test. The lymphocytes are contacted with an antigen capable of stimulating them to produce MIF. The leucocyte migration is inhibited and fixed after a predetermined period of time. The leucocytes migrate in a capillary intermediate layer having a thickness of from 1 to 20 microns and being at least partially filled with liquid. Said intermediate layer is formed between a glass surface and an agar layer. The invention further refers to the construction and preparation of a testing plate or dish comprising these layers.
ES475905A 1977-12-12 1978-12-11 Test method for detection of malignant tumours Expired ES475905A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2755363A DE2755363C3 (en) 1977-12-12 1977-12-12 Test method for diagnosing malignancies

Publications (1)

Publication Number Publication Date
ES475905A1 true ES475905A1 (en) 1979-10-16

Family

ID=6025947

Family Applications (2)

Application Number Title Priority Date Filing Date
ES475905A Expired ES475905A1 (en) 1977-12-12 1978-12-11 Test method for detection of malignant tumours
ES1979243564U Expired ES243564Y (en) 1977-12-12 1979-05-25 AN IN VITRO TEST PLATE FOR DIAGNOSIS OF MA-LLIGNOS TUMORS.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES1979243564U Expired ES243564Y (en) 1977-12-12 1979-05-25 AN IN VITRO TEST PLATE FOR DIAGNOSIS OF MA-LLIGNOS TUMORS.

Country Status (25)

Country Link
JP (1) JPS54100176A (en)
AR (1) AR220356A1 (en)
AT (1) AT360178B (en)
AU (1) AU4234978A (en)
BE (1) BE872651A (en)
CA (1) CA1129319A (en)
CH (1) CH646793A5 (en)
DD (1) DD139903A5 (en)
DE (1) DE2755363C3 (en)
DK (1) DK532678A (en)
ES (2) ES475905A1 (en)
FI (1) FI783782A (en)
FR (1) FR2411412A1 (en)
GB (1) GB2009927B (en)
GR (1) GR66576B (en)
IL (1) IL56152A0 (en)
IT (1) IT1160323B (en)
LU (1) LU80609A1 (en)
NL (1) NL7811903A (en)
NO (1) NO784096L (en)
PL (1) PL112675B1 (en)
PT (1) PT68891A (en)
RO (1) RO75333A (en)
SE (1) SE432157B (en)
ZA (1) ZA786908B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4436824A (en) * 1981-06-09 1984-03-13 Ortho Diagnostic Systems, Inc. Leukocyte migration through antigen containing agaroses for immunocompetence testing
JPH0672158B2 (en) * 1984-05-24 1994-09-14 チバ−ガイギ− アクチエンゲゼルシヤフト Purified human macrophage migration inhibitory factor

Also Published As

Publication number Publication date
RO75333A (en) 1980-11-30
ATA872478A (en) 1980-05-15
FR2411412B3 (en) 1981-03-27
LU80609A1 (en) 1979-05-16
CH646793A5 (en) 1984-12-14
DE2755363A1 (en) 1979-06-13
PL211672A1 (en) 1979-09-10
JPS54100176A (en) 1979-08-07
DD139903A5 (en) 1980-01-23
DK532678A (en) 1979-06-13
NO784096L (en) 1979-06-13
DE2755363C3 (en) 1983-12-01
FI783782A (en) 1979-06-13
ES243564U (en) 1980-06-01
ZA786908B (en) 1979-12-27
BE872651A (en) 1979-03-30
FR2411412A1 (en) 1979-07-06
ES243564Y (en) 1980-12-16
GR66576B (en) 1981-03-27
SE432157B (en) 1984-03-19
GB2009927A (en) 1979-06-20
IT1160323B (en) 1987-03-11
AR220356A1 (en) 1980-10-31
CA1129319A (en) 1982-08-10
IT7830722A0 (en) 1978-12-12
DE2755363B2 (en) 1979-12-20
GB2009927B (en) 1982-10-06
PT68891A (en) 1979-07-24
AU4234978A (en) 1979-06-21
PL112675B1 (en) 1980-10-31
AT360178B (en) 1980-12-29
IL56152A0 (en) 1979-03-12
NL7811903A (en) 1979-06-14
SE7812313L (en) 1979-06-13

Similar Documents

Publication Publication Date Title
Tourtellotte et al. Cerebrospinal fluid electroimmunodiffusion: An easy, rapid, sensitive, reliable, and valid method for the simultaneous determination of immunoglobulin-G and albumin
Smith et al. Low-density lipoprotein concentration in interstitial fluid from human atherosclerotic lesions: relation to theories of endothelial damage and lipoprotein binding
SE7509710L (en) METHODS AND APPARATUS FOR PERFORMING MEDICAL DIAGNOSIS
DE69415821T2 (en) INTERSTITIAL LIQUID EXTRACTION AND MEASUREMENT OF INGREDIENTS
HIGASHI et al. Tumor-associated expression of glycosphingolipid Hanganutziu-Deicher antigen in human cancers
Horvath et al. Muscular dystrophy. Cation concentrations in residual muscle
CN101275954A (en) Breast cancer early warning chip for easily rapid measuring human I type thymidine kinase gene protein
Manx Study of peripheral circulation by means of an alternating current bridge
ES8605098A1 (en) Method of measuring ligands.
MX4962E (en) PROCESS FOR THE PRODUCTION OF AN IMPROVED DIAGNOSTIC COMPOSITION FOR THE DETECTION OF HEPATITIS B SURFACE ANTIGEN IN HUMAN BLOOD
ES475905A1 (en) Test method for detection of malignant tumours
Didierjean et al. Biologically active interleukin 1 in human eccrine sweat: Site-dependent variations in α/β ratios and stress-induced increased excretion
IT1114861B (en) METHOD FOR DETERMINING THE CONTENT OF CONSTITUENTS OF BIOLOGICAL FLUIDS AND MEANS SUITABLE FOR THE PURPOSE
Burg et al. Patterns of Cutaneous Lymphomas: Histological, Enzyme Cytochemical, and Immunological Typing of Lymphoreticular Proliferations in the Skin
OA08331A (en) Monoclonal antibodies, cell lines and kits containing them for diagnosing epitheliomas of human lungs not containing small cells;
Denz et al. Urinary neopterin as a prognostic factor in haematological neoplasias
Kenney et al. Skin blister immunocytology A new method to quantify cellular kinetics in vivo
Tyler et al. Interleukin-1 production in tumor cells of human melanoma surgical specimens
Niemtzow Transmembrane potentials of human lymphocytes
US4632743A (en) Method for examining cells by electrophoresis
Neunteufel et al. Serum squamous cell carcinoma antigen levels in women with neoplasms of the lower genital tract and in healthy controls
Tewari et al. Migration inhibition of normal rat thymocytes as an in vitro method for detecting cell-mediated immunity in rat and mouse
Larsen et al. Serum proteins in the hedgehog
VAN LEEUWEN et al. Corticotropin and Cortisone in Rheumatic Fever: Preliminary Report of the Effect on the Electrophoretic Patterns of Plasma or Serum Proteins of Children
Birnbaum et al. Thymic lymphocytes in myasthenia gravis